Fundamentals to Apply Magnetic Nanoparticles for Hyperthermia Therapy

Overview

Journal Nanomaterials (Basel)

Date 2021 Jun 2

PMID 34062851

Citations 46

Authors

Hira Fatima

Tawatchai Charinpanitkul

Kyo-Seon Kim

Affiliations

Soon will be listed here.

Abstract

The activation of magnetic nanoparticles in hyperthermia treatment by an external alternating magnetic field is a promising technique for targeted cancer therapy. The external alternating magnetic field generates heat in the tumor area, which is utilized to kill cancerous cells. Depending on the tumor type and site to be targeted, various types of magnetic nanoparticles, with variable coating materials of different shape and surface charge, have been developed. The tunable physical and chemical properties of magnetic nanoparticles enhance their heating efficiency. Moreover, heating efficiency is directly related with the product values of the applied magnetic field and frequency. Protein corona formation is another important parameter affecting the heating efficiency of MNPs in magnetic hyperthermia. This review provides the basics of magnetic hyperthermia, mechanisms of heat losses, thermal doses for hyperthermia therapy, and strategies to improve heating efficiency. The purpose of this review is to build a bridge between the synthesis/coating of magnetic nanoparticles and their practical application in magnetic hyperthermia.

Citing Articles

Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses.

Soko G, Kosgei B, Meena S, Ng Y, Liang H, Zhang B Front Immunol. 2025; 15():1535647.

PMID: 39845957 PMC: 11751056. DOI: 10.3389/fimmu.2024.1535647.

Evaluating the impact of cell-penetrating motif position on the cellular uptake of magnetite nanoparticles.

Salgado L, Cifuentes-Delgado P, Orozco J, Munoz-Camargo C, Reyes L, Quezada V Front Bioeng Biotechnol. 2024; 12:1450694.

PMID: 39687269 PMC: 11646778. DOI: 10.3389/fbioe.2024.1450694.

Cancer treatment approaches within the frame of hyperthermia, drug delivery systems, and biosensors: concepts and future potentials.

Sayed Z, Hieba E, Batakoushy H, Rashdan H, Ismail E, Elkatlawy S RSC Adv. 2024; 14(53):39297-39324.

PMID: 39670162 PMC: 11635600. DOI: 10.1039/d4ra06992g.

Utilization of nanomaterials in MRI contrast agents and their role in therapy guided by imaging.

Wang W, Shang S, Wang Y, Xu B Front Bioeng Biotechnol. 2024; 12:1484577.

PMID: 39628648 PMC: 11611570. DOI: 10.3389/fbioe.2024.1484577.

A New Spin on Material Properties: Local Magnetic Structure in Functional and Quantum Materials.

Frandsen B, Fischer H Chem Mater. 2024; 36(19):9089-9106.

PMID: 39398371 PMC: 11467898. DOI: 10.1021/acs.chemmater.4c01535.

References

Kim D, Kim K, Kim K, Lee Y . Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia. J Biomed Mater Res A. 2008; 88(1):1-11. DOI: 10.1002/jbm.a.31775. View

Lee J, Jang J, Choi J, Moon S, Noh S, Kim J . Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol. 2011; 6(7):418-22. DOI: 10.1038/nnano.2011.95. View

Zhang J, Dewilde A, Chinn P, Foreman A, Barry S, Kanne D . Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia. Int J Hyperthermia. 2011; 27(7):682-97. DOI: 10.3109/02656736.2011.609863. View

Salunkhe A, Khot V, Pawar S . Magnetic hyperthermia with magnetic nanoparticles: a status review. Curr Top Med Chem. 2014; 14(5):572-94. DOI: 10.2174/1568026614666140118203550. View

Kafrouni L, Savadogo O . Recent progress on magnetic nanoparticles for magnetic hyperthermia. Prog Biomater. 2016; 5(3-4):147-160. PMC: 5304434. DOI: 10.1007/s40204-016-0054-6. View

Brero F, Albino M, Antoccia A, Arosio P, Avolio M, Berardinelli F . Hadron Therapy, Magnetic Nanoparticles and Hyperthermia: A Promising Combined Tool for Pancreatic Cancer Treatment. Nanomaterials (Basel). 2020; 10(10). PMC: 7600442. DOI: 10.3390/nano10101919. View

DeNardo S, DeNardo G, Miers L, Natarajan A, Foreman A, Gruettner C . Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res. 2005; 11(19 Pt 2):7087s-7092s. DOI: 10.1158/1078-0432.CCR-1004-0022. View

Olsen D, Yang C, Bodo M, Chang R, Leigh S, Baez J . Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev. 2003; 55(12):1547-67. DOI: 10.1016/j.addr.2003.08.008. View

Sadhukha T, Niu L, Wiedmann T, Panyam J . Effective elimination of cancer stem cells by magnetic hyperthermia. Mol Pharm. 2013; 10(4):1432-41. DOI: 10.1021/mp400015b. View

10.

Lin T, Lin F, Lin J . In vitro feasibility study of the use of a magnetic electrospun chitosan nanofiber composite for hyperthermia treatment of tumor cells. Acta Biomater. 2012; 8(7):2704-11. DOI: 10.1016/j.actbio.2012.03.045. View

11.

Garaio E, Sandre O, Collantes J, Angel Garcia J, Mornet S, Plazaola F . Specific absorption rate dependence on temperature in magnetic field hyperthermia measured by dynamic hysteresis losses (ac magnetometry). Nanotechnology. 2014; 26(1):015704. DOI: 10.1088/0957-4484/26/1/015704. View

12.

Lu A, Salabas E, Schuth F . Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl. 2007; 46(8):1222-44. DOI: 10.1002/anie.200602866. View

13.

Shan G, Xing J, Luo M, Liu H, Chen J . Immobilization of Pseudomonas delafieldii with magnetic polyvinyl alcohol beads and its application in biodesulfurization. Biotechnol Lett. 2004; 25(23):1977-81. DOI: 10.1023/b:bile.0000004388.15751.8c. View

14.

Martin-Saavedra F, Ruiz-Hernandez E, Bore A, Arcos D, Vallet-Regi M, Vilaboa N . Magnetic mesoporous silica spheres for hyperthermia therapy. Acta Biomater. 2010; 6(12):4522-31. DOI: 10.1016/j.actbio.2010.06.030. View

15.

Kawai N, Ito A, Nakahara Y, Futakuchi M, Shirai T, Honda H . Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate. 2005; 64(4):373-81. DOI: 10.1002/pros.20253. View

16.

Yang M, Ho C, Ruta S, Chantrell R, Krycka K, Hovorka O . Magnetic Interaction of Multifunctional Core-Shell Nanoparticles for Highly Effective Theranostics. Adv Mater. 2018; 30(50):e1802444. PMC: 11284570. DOI: 10.1002/adma.201802444. View

17.

Hervault A, Thanh N . Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale. 2014; 6(20):11553-73. DOI: 10.1039/c4nr03482a. View

18.

Liu X, Yang Y, Ng C, Zhao L, Zhang Y, Bay B . Magnetic vortex nanorings: a new class of hyperthermia agent for highly efficient in vivo regression of tumors. Adv Mater. 2015; 27(11):1939-44. DOI: 10.1002/adma.201405036. View

19.

Giustini A, Petryk A, Cassim S, Tate J, Baker I, Hoopes P . MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT. Nano Life. 2013; 1(1n02). PMC: 3859910. DOI: 10.1142/S1793984410000067. View

20.

Devarajan P, Jindal A, Patil R, Mulla F, Gaikwad R, Samad A . Particle shape: a new design parameter for passive targeting in splenotropic drug delivery. J Pharm Sci. 2010; 99(6):2576-81. DOI: 10.1002/jps.22052. View